This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90-count packages, with a potential value of $1,333.74 and a completion date of February 6, 2024. The contract has no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award and...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 90 tablets of the prescription medication Valsartan-HCTZ 160-12.5 mg, with a potential value of $8,219.58 and a completion date of February 21, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division, is the prime contractor on this delivery order. No set-aside designation...
This is a federal delivery order contract award to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4565901004 VALSARTAN-HCTZ 320-12.5 MG TAB 90S, with a firm fixed price ceiling value of $11,657.87 and a completion date of September 24, 2024. This award is not associated with a set-aside program. Amerisourcebergen, through its extensive supply chain network, provides a wide...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, the prime contractor. The order is for 4,563,954,860 units of the pharmaceutical product Valsartan-HCTZ 320-12.5 mg tablets in 90-count packages, with a total ceiling value of $7,482.58. The order has a performance period through March 14, 2024. Amerisourcebergen Drug Corporation is a subsidiary of Amerisourcebergen Corporation, a global...
This federal contract award, identified as SPE2DB20D3101 and SPE2DB25FQWX3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-HCTZ 160-25 mg tablets in 90-count packages, with a ceiling value of $1,067.90 and a completion date of December 13, 2024. The contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for Valsartan-HCTZ 320-25 mg tablets, with a potential value of $19,362.96 and a completion date of February 29, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of valsartan-HCTZ 320-25 mg tablets in 90-count bottles, with a ceiling value of $5,955.68 and a period of performance through May 1, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is one of the largest pharmaceutical distribution companies in the world....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90-count packaging, with a completion date of February 14, 2024 and a potential value of $2,140.15. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The award is for the supply of Valsartan-HCTZ 320-25 mg tablets in 90 count bottles. The order has a ceiling value of $10,280.69 and an ultimate completion date of January 14, 2022. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 90-count packages of the pharmaceutical product Valsartan-HCTZ 320-12.5 mg tablets. The contract has a ceiling value of $6,147.81 and a period of performance through April 4, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of...